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background: Recently, we demonstrated that single blastomeres of a 4-cell stage human embryo are able to develop into blastocysts
with inner cell mass and trophectoderm. To further investigate potency at the 4-cell stage, we aimed to derive pluripotent human embryonic
stem cells (hESC) from single blastomeres.
methods: Four 4-cell stage embryos were split on Day 2 of preimplantation development and the 16 blastomeres were individually cul-
tured in sequential medium. On Day 3 or 4, the blastomere-derived embryos were plated on inactivated mouse embryonic ﬁbroblasts
(MEFs).
results: Ten out of sixteen blastomere-derived morulae attached to the MEFs, and two produced an outgrowth. They were mechani-
cally passaged onto fresh MEFs as described for blastocyst ICM-derived hESC, and shown to express the typical stemness markers by
immunocytochemistry and/or RT–PCR. In vivo pluripotency was conﬁrmed by the presence of all three germ layers in the teratoma obtained
after injection in immunodeﬁcient mice. The ﬁrst hESC line displays a mosaic normal/abnormal 46, XX, dup(7)(q33qter), del(18)(q23qter)
karyotype. The second hESC line displays a normal 46, XY karyotype.
conclusion: We report the successful derivation and characterization of two hESC lines from single blastomeres of four split 4-cell
stage human embryos. These two hESC lines were derived from distinct embryos, proving that at least one of the 4-cell stage blastomeres
is pluripotent.
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Introduction
Totipotency is deﬁned as the capacity of a single cell to produce fertile
offspring (Tarkowski et al., 2001). Totipotency is lost when the cell
becomes restricted in differentiation capacity. Subsequently, this cell
becomes pluripotent, unipotent and ﬁnally differentiates into a special-
ized cell. The totipotent cell is -on its own- able to divide and produce
the extra-embryonic tissues necessary for implantation and foetal
development, and all the differentiated cells composing a new
organism including germ cells. The ultimate totipotent cell is the
zygote. During cleavage divisions, the zygote divides into blastomeres
that appear morphologically identical. The ﬁrst sign of developmental
restriction becomes apparent with the segregation of the two distinct
cell lineages during blastocyst formation: the trophectoderm (TE) and
the inner cell mass (ICM). How and when blastomeres lose their toti-
potent competence during preimplantation development is still
unknown. In animal models, the potency of single blastomere-derived
embryos can be deﬁned by transferring them into the uterus of foster
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embryos. Split 4-cell stage murine embryos implant but do not
develop to term, most likely because of lack in embryo mass. Proof
that at least two cells of a 4-cell stage mouse embryo are totipotent
was provided after aggregation of diploid 4-cell stage blastomeres
with tetraploid carrier blastomeres resulting in the production of a
fertile diploid twin (reviewed in Tarkowski et al., 2001). To our knowl-
edge, the bovine is the only example in which all four blastomeres of a
single embryo developed into live offspring (a monozygotic quadru-
plet) (Johnson et al. 1995).
Recently, we have shown that the sister blastomeres of a 4-cell
stage human embryo are plastic and have the capacity to develop in
vitro into blastocysts with ICM and TE (Van de Velde et al., 2008).
Our hypothesis is that the 4-cell stage human blastomeres are equal
and totipotent. In the human, totipotency of cleavage-stage blasto-
meres cannot be proven because cloning experiments are ethically
unacceptable. Therefore, we consider the 4-cell stage blastomeres
to be ‘potentially totipotent’. Evidence that at least one single blasto-
mere of a 4-cell human embryo is totipotent was provided by the birth
of a healthy baby after the transfer of a frozen-thawed embryo of
which only one out of four blastomeres was intact (Veiga et al.,
1987;Veiga, personal communication).
To further evaluate the potency of the blastomeres at the 4-cell
stage, we aimed to derive human embryonic stem cell (hESC) lines
from the four sister blastomeres. Human ICM cells and ICM-
derived embryonic stem cell lines are considered to be pluripotent.
HESC have the capacity to differentiate into cell types representing
the three embryonic germ layers both in vitro (i.e. in embryoid
bodies) and in vivo (i.e. in teratomas formed in immunodeﬁcient
mice) (Thomson et al., 1998; Reubinoff et al., 2000). They also
have the capacity to differentiate in vitro into specialized cells,
including germ cells, extra-embryonic tissue and trophoblast cells
(Xu et al. 2002; Hyslop et al. 2005). Therefore, the capacity of a
single blastomere to develop into a hESC line could be used to
deﬁne the pluripotency of that cell. We report here the derivation
of two hESC lines from single blastomeres of distinct 4-cell stage
human embryos.
Materials and Methods
Derivation and culture
With the approval of the Belgian Federal Committee on medical and scien-
tiﬁc research on embryos in vitro and the Local Ethical Committee, in vitro
fertilized embryos were created. Oocytes of three consenting patients
(age 26, 35 and 37, respectively) were denuded and injected with sperma-
tozoa from a consenting donor on the day of oocyte pick up (OPU). Fer-
tilization was assessed 16–22 h after injection. On Day 2 after OPU, four
top quality 4-cell stage embryos with equally-sized blastomeres and less
than 10% fragmentation (estimated as a proportion of the total embryo
volume) were split. The 16 single blastomeres were cultured individually
as described earlier, but in contrast to our earlier work, without zona pel-
lucida (Van de Velde et al., 2008). On Day 3 or 4 (Table I) after OPU, the
resulting 16 blastomere-derived embryos were washed, plated in individual
wells of a 24-well dish coated with mitomycin C-inactivated CF1 mouse
embryonic ﬁbroblasts (MEFs) and cultured in hESC medium as described
previously (Mateizel et al., 2006). Whenever an outgrowth was present,
it was mechanically passaged and cultured as described for blastocyst ICM-
derived hESC. A modiﬁed vitriﬁcation protocol was used for cryopreserva-
tion (Reubinoff et al., 2001; Mateizel et al., 2006).
Characterization
The expression of SSEA-3, SSEA-4, TRA-1-60 and TRA-1-81, cell surface
markers that characterize undifferentiated hESC was assessed by immuno-
cytochemistry (Mateizel et al., 2006). The primary antibodies used were
SSEA-3 [MC-631, Developmental Studies Hybridoma Bank (DSHB),
Iowa, USA; 1:20], SSEA-4 (MC-813, DSHB, 1:20), TRA-1-60
(MAB4360, 1:100), TRA-1-81 (MAB4381), (both Millipore, Brussels,
.............................................................................................................................................................................................
Table I Overview of the embryos used in this study.
Original
embryo
Oocyte donor
age
Embryo Developmental stage before
plating
Plated Attached Outgrowth hESC line
1 35 1.1 compacted 1 22 2
1.2 compacted lost 22 2
1.3 compacted 11 22
1.4 compacted 11 1 VUB26_QUATRO
2 35 2.1 compacting 11 22
2.2 compacting 11 22
2.3 6 cells 11 22
2.4 compacting 1 22 2
3 37 3.1 compacting 11 22
3.2 compacted 1 22 2
3.3 compacted 11 22
3.4 compacted 11 22
4 26 4.1 2 cells 11 22
4.2 2 cells 11 1 VUB27_PATRU
4.3 2 cells 1 22 2
4.4 2 cells 1 22 2
Total number 16 15 10 2 2
The ﬁrst three embryos were used in one study in which the resulting morulae were plated on Day 4 after ovarian pick up (OPU), resulting in VUB26_QUATRO. For the fourth embryo,
plating was performed on day 3 after OPU, resulting in VUB27_PATRU.
2710 Geens et al.Belgium; 1:100). For the detection of the primary antibodies, Alexa488-
conjugated secondary antibodies (Invitrogen, Merelbeke, Belguim; 1:250)
were used. Gene expression studies for stemness markers (POU5F1,
NANOG, DNMT3B, GDF3, LIN 28, NPM 1, REX-1, SOX-2) and alpha-
fetoprotein (AFP) as a marker for differentiated cells were carried out
on predominantly undifferentiated stem cells by qualitative reverse tran-
scriptase–PCR (RT–PCR) (Mateizel et al., 2006). RNA was isolated
using the RNeasy Mini Kit (Qiagen, Venlo, Netherlands) and was
reverse transcribed to cDNA using the First-strand cDNA Synthesis Kit
(GE Healthcare, Diegem, Belgium) with the NotI-d(T)18 primer. PCR
was performed using 2 ml of cDNA in a 25 ml total PCR volume containing
10 pmol of primers, 0.2 mmol dNTP and 2.5 U of Taq polymerase (GE
Healthcare). For DNMT3B, PCR was performed using the Expand High
Fidelity PCR System (Roche Diagnostics GmbH, Mannheim, Germany).
.............................................................................................................................................................................................
Table II The primer sequences and conditions of the PCRs for the gene expression studies.
gene Forward primer Reverse primer Annealing temperature
(8 8 8 8 8C)
Product size
(bp)
NANOG CAGAAGGCCTCAGCACCTAC CTGTTCCAGGCCTGATTGTT 55 216
POU5F1 GACAACAATGAGAACCTTCAGGAGA TTCTGGCGCCGGTTACAGAACCA 55 218
HPRT GCCGGCTCCGTTATGGCG AGCCCCCCTTGAGCACACAGA 55 226
REX-1 GCGTACGCAAATTAAAGTCCAGA CAGCATCCTAAACAGCTCGCAGAAT 58 306
SOX-2 CCCCCGGCGGCAATAGCA TCGGCGCCGGGGAGATACAT 58 448
LIN 28 AGTAAGCTGCACATGGAAGG ATTGTGGCTCAATTCTGTGC 58 420
NPM1 TGGTGCAAAGGATGAGTTGC GTCATCATCTTCATCAGCAGC 58 343
GDF3 AGACTTATGCTACGTAAAGGAGCT CTTTGATGGCAGACAGGTTAAAGT 58 150
DNMT3B TTGTAGCCATGAAGGTTGGC TGTGTAGTGCACAGGAAAGC 59 351
AFP GCTGGATTGTCTGCAGGATGGGGAA TCCCCTGAAGAAAATTGGTTAAAAT 55 216
Figure 1 The morphological features of four blastomeres-derived morulae from the same embryo (days after OPU).
Pictures were taken by 200  original magniﬁcation.
hESC lines from single 4-cell stage blastomeres 2711The primer sequences and conditions of the PCRs (35 cycles) are
described in Table II. PCR products were analyzed on a 2% agarose gel.
For the detection of alkaline phosphatase activity, the Vector Blue sub-
strate kit (Vector Laboratories, Burlingame CA, USA) was used. Terato-
mas were obtained after injection of 2   10
7 cells into the rear leg
muscle of a SCID mouse. Karyotyping was done by array Comparative
Genomic Hybridization (aCGH, Vermeesch et al., 2005) and G-banding
(Gosden et al., 1992).
Results
Four top quality 4-cell stage human embryos were split into single blas-
tomeres that were used for hESC derivation. Two pluripotent hESC
lines were derived from distinct 4-cell stage embryos.
For the ﬁrst line, three top quality 4-cell stage embryos were split
into 12 single blastomeres that were cultured individually without
zona pellucida. The 12 single blastomeres showed synchronous
mitotic divisions and divided into two cells on Day 3. On Day 4,
they all developed into small morulae (estimated 4–8 cells), some
compacting (cell contours microscopically visible) and others fully
compacted (no cell contours microscopically visible) (Table I). From
the 12 blastomere-derived embryos, one was lost during the plating
procedure and the remaining 11 were plated. On Day 5, 1 day after
plating, 8 out of 11 blastomere-derived embryos attached to the
MEFs. The ones that did not attach originated from three distinct
embryos and degenerated without showing any sign of cavitation.
We did not observe that all four cells of a single embryo led to attach-
ing morulae, i.e. of every split embryo one blastomere-derived morula
did not attach. Seven out of eight attached morulae subsequently
degenerated without showing any sign of cavitation. The morphologi-
cal features of four blastomere-derived morulae from the same
embryo are shown in Fig. 1. Without showing any sign of cavitation,
one blastomere-derived morula produced an outgrowth represented
by a compact group of cells (Fig. 2b and c) (age mother 35,
Figure 2 Derivation of the hESC lines VUB26_QUATRO (a–h) and VUB27_PATRU (i–p) by plating and outgrowth of a single blastomere-derived
morula (days after OPU).
VUB26_QUATRO:Theblastomere-derivedmorula(a)producedanoutgrowth(arrow)representedbyacompactgroupofcells(b,c).Fourdaysafterplating,ﬂattenedTE-like
cells were visible (d) but they did not survive the following days (e). By Day 16, hESC-like cells were visible for the ﬁrst time (f). They subsequently developed into a hESC
colony-like structure (g) that was mechanically passaged and cultured further (h). VUB27_PATRU: the blastomere-derived morula attached to the ﬁbroblast feeder layer
at Day 5 (j). Starting from Day 6 (k), a colony-like structure developed and continued to expand (l–o). It was mechanically passaged on Day 23 and cultured further (p).
2712 Geens et al.Table I). On Day 8, 4 days after plating, ﬂattened TE-like cells were
visible (Fig. 2d) but they did not survive the following days (Fig. 2e).
No hESC-like cells were observed. However, by Day 16, hESC-like
cells were visible for the ﬁrst time (Fig. 2f). They subsequently devel-
oped into a hESC colony-like structure that was mechanically passaged
on Day 22 and cultured further as described for blastocyst ICM-
derived hESC (Fig. 2 g and h).
The putative hESC line VUB26_QUATRO expressed the typical
markers of stemness (SSEA-3, SSEA-4, TRA-1-60, TRA-1-81,
POU5F1, NANOG, DNMT3B, GDF3, LIN 28, NPM 1, REX-1, SOX-2
and Alkaline Phosphatase) as detected by immunocytochemistry
and/or RT–PCR performed at passage 18 and 13, respectively
(Figs. 3 and 4a). After the ﬁrst passage, the colony morphology and
growth rates were similar to blastocyst ICM-derived hESC (data not
shown). At passage 10, cells were collected for molecular karyotyping
by aCGH and were shown to carry a deletion of chromosome
18q23qter and a duplication of chromosome 7q33qter (46, XX,
dup(7)(q33qter), del(18)(q23qter)) (Fig. 5). This was conﬁrmed at
passage 35 when a derivative chromosome 18 was visualized by
G-banding (Fig. 5), however, two out of six metaphases showed a
normal karyotype. In vivo pluripotency was conﬁrmed by the presence
of derivatives of all three germ layers in the teratoma that was
observed and collected 9 weeks after injection: squamous epithelium
(ectoderm), cartilage (mesoderm) and gastro-intestinal epithelium
(endoderm) (Fig. 6A). At present, VUB26_QUATRO is at passage
60 and it has been successfully frozen-thawed and reintroduced into
culture.
For the second line, one top quality 4-cell stage embryo (age
mother 26, Table I) was split into four single blastomeres and cultured
individually without zona pellucida. As was described for the ﬁrst hESC
line, the four single blastomeres showed synchronous mitotic divisions
and divided into two cells on Day 3. They were plated on Day 3 for
practical reasons, on Day 4 the four blastomere-derived embryos
showed signs of compaction. On Day 5, 2 days after plating, two
out of four blastomere-derived embryos attached to the MEFs and
one produced an outgrowth as described above for the ﬁrst hESC
line (Fig. 2). This putative hESC line VUB27_PATRU also expressed
the typical markers of stemness as detected by immunocytochemistry
and/or RT–PCR performed at passage 49 and 50, respectively (Figs. 3
and 4b). At passage 9, cells were collected for molecular karyotyping
by aCGH and were shown to display a normal 46, XY karyotype (see
Supplementary Figure S1). The presence of derivatives of all three
germ layers in the teratoma that was observed and collected 10
weeks after injection, conﬁrmed in vivo pluripotency: retina progeni-
tors (ectoderm), cartilage (mesoderm) and glandular epithelium with
Goblet cells (endoderm) (Fig. 6B). At present, VUB27_PATRU is at
passage 67, it has been frozen and the survival capacity after
thawing will be assessed.
Discussion
This report describes the successful derivation and characterization of
hESC lines from 2 out of 16 single blastomeres isolated from four top
quality 4-cell stage human embryos (success rate of 12.5%). These
two blastomere-derived hESC lines were obtained from distinct
embryos. Recently, the group of Feki et al. (2008) also reported the
derivation of a hESC line from a single blastomere of a frozen-thawed
4-cell stage embryo in which only one blastomere survived thawing.
We conclude that at least one blastomere is pluripotent at the
4-cell stage. However, to provide evidence that the four cells are
equal and pluripotent, a hESC line should have been derived from
each of the four sister blastomeres. Given the success rate of classic
hESC derivation from blastocysts ICM (about 7% in our hands), a
large number of embryos would have to be subjected to similar exper-
iments which is practically almost impossible given the scarcity of the
material.
Stable ESC lines have been derived from single blastomeres of
4- and 8-cell stage mouse embryos (Chung et al., 2005; Lorthongpa-
nich et al., 2008). HESC lines derived from single blastomeres of
8-cell stage human embryos have also been reported (Klimanskaya
Figure 3 Gene expression studies on VUB26_QUATRO and VUB27_PATRU: immunocytochemical detection of SSEA-3, SSEA-4, TRA-1-60 and
TRA-1-81; Alkaline Phosphatase positive colonies.
hESC lines from single 4-cell stage blastomeres 2713et al., 2006, 2007); however, the success rate was very low (2%) and
co-culture with an established hESC line in order to create a stem cell
niche was necessary. Recently, the derivation rate was improved
(20%) by co-culturing the blastomere with the parent embryo and
by adding laminin to the medium (Chung et al., 2008). The protocol
was further simpliﬁed by omitting co-culturing with hESC. We
describe a simple method to derive hESC lines by plating blastomere-
derived embryos on MEFs on which they attach spontaneously. No
sign of cavitation was observed conﬁrming that in order to derive
ESC lines from cleavage-stage embryos (Tesar, 2005) or single blasto-
meres (Chung et al., 2008), blastulation is not necessary. Our deri-
vation procedure does not include co-culture of the single
blastomere with the parent embryo (Chung et al., 2008) or co-culture
of the blastomere-derived so-called ‘vesicle’ with an existing hESC line
(Klimanskaya et al., 2006, 2007). Moreover, presence of laminin in the
medium is not essential in our protocol, although this might still
improve the hESC derivation rate (Chung et al., 2008). Our protocol
is similar to the one described by Feki et al. (2008) who obtained a
karyotypically abnormal hESC line from a single blastomere of an
arrested 4-cell stage embryo plated on human foreskin ﬁbroblasts.
An important question concerns the chromosomal abnormality that
was observed in the VUB26_QUATRO hESC line. Array-CGH
showed that the hESC line carried a duplication 7q33qter and a del-
etion 18q23qter. G-banding showed that the abnormality was a
derivative chromosome 18 and that the line was mosaic 46, XX/46,
XX, der(18). Our second hESC line VUB27_PATRU displays a
normal (46, XY) karyotype at passage 9 as shown by array-CGH.
Comparing the genetic constitution of the two blastomere-derived
VUB hESC lines, we do not believe the genetic abnormalities observed
in VUB26_QUATRO were caused by the age of the mother or by the
slightly different hESC derivation methodology. The fact that the line
was mosaic for the derivative 18 strongly indicates that the abnormal-
ity was acquired in culture. Further characterization of the abnormality
and discussion on the mechanism of origin and the role of the deriva-
tive 18 in cell survival can be found in Spits et al. (2008). Feki et al.
(2008) also reported that their hESC line was chromosomally abnor-
mal with triploidies and several deletions and duplications. Coming
from a thawed 4-cell stage embryo of which only one blastomere sur-
vived, the multiple chromosomal abnormalities in their line probably
originated from the embryo rather than from the in vitro culture
conditions.
HESC lines have been derived from blastocyst ICM cells (Thomson
et al., 1998; Mateizel et al., 2006), morulae (Strelchenko et al., 2004;
Strelchenko and Verlinsky, 2006), chromosomally abnormal embryos
(Munne ´ et al., 2005), abnormally developing or arrested embryos
(Zhang et al., 2006) and single blastomeres of 8-cell stage embryos
(Klimanskaya et al., 2006, 2007; Chung et al., 2008) and 4-cell stage
embryos (Feki et al. (2008) and the present report). Marked differ-
ences in expression and differentiation potential between these dis-
tinct hESC lines are to be expected especially because variation
between blastocyst ICM-derived hESC lines has already been
described (Osafune et al., 2008). Differences could be due to the
stage of embryonic development at derivation, variation in techniques
of derivation, culturing and passaging methods, chromosomal or other
genetic abnormalities and epigenetic variability. In particular, epige-
netic mechanisms such as transient histone modiﬁcations at the level
of key developmental genes seem to play a major role in ESC pluripo-
tency and cell lineage determination (Gan et al., 2007). Due to asyn-
chronous epigenetic mechanisms, heterogeneity may be created in
morphologically homogeneous ICM cells as well as in the blastomeres
at earlier stages of development. Thus epigenetic plasticity may play a
key role in maintaining totipotency/pluripotency.
Through the establishment of a hESC from a cell obtained from a
blastomere at a 4-cell stage embryo, we provide evidence of pluripo-
tency at that particular stage of development. In addition, this ﬁnding
may have important ethical consequences, since the embryo, in con-
trast to prior methods to derive embryonic stem cells, is not
destroyed. Hence, the hESC obtained from the embryo could be
used as savior cells for tissue regeneration in several models of
human disease, e.g. hematopoietic stem cells (HSC), kidney cells
and pancreatic beta-cells. Currently, preimplantation genetic diagnosis
(PGD) is used to obtain a human leukocyte antigen (HLA)-matched
Figure 4 Gene expression studies on VUB26_QUATRO (A) and
VUB27_PATRU (B): RT–PCR results for stemness markers
DNMT3B, GDF3, LIN 28, NPM 1, REX-1, SOX-2, POU5F1 and
NANOG; housekeeping gene HPRT and alpha-fetoprotein (AFP)a sa
marker for differentiated cells.
In Fig. 4A, expression of HPRT and AFP was assessed in embryoid bodies from a
fully characterized hESC line (VUB01) as a positive control for the differen-
tiation marker AFP (HPRT EB, AFP EB).
2714 Geens et al.child as a donor for cord blood HSC to transplant and save a sibling
with bone marrow failure syndromes or other hematological diseases
(Bielorai et al., 2004; Grewal et al., 2004). This so-called PGD/HLA
testing type 1 (de Wert et al., 2007) is morally accepted in most
countries on the condition that the parents intend to care for the
donor child to the same extend as they do for their other children
and because the newborn is not harmed when collecting the cord
blood. However, this approach is limited by several factors including
implantation rate and the duration of the pregnancy for those cases
requiring urgent transplantation. An alternative option for the
parents would be not to transfer the HLA-matched embryo but to
derive a hESC line for the in vitro generation of HSC for cell therapy
(PGD/HLA testing type 2) (de Wert et al., 2007). Using the conven-
tional hESC derivation methodology starting from blastocyst ICM cells,
the embryo would be destroyed. By deriving a hESC line from a 4-cell
stage embryo, the attempt to conceive an HLA-matched healthy baby
could be theoretically combined with the derivation of a hESC line
thereby increasing the possibilities to cure the sick child after HSC
transplantation. Likewise, the hESC could be used to generate cell
types for other, more experimental cellular therapy.
At present, the hESC derivation rate starting from one blastomere
of cleavage-stage embryos is too low for clinical application. Also,
before clinical application, hESC derivation and differentiation in clinical
grade conditions need to be proven efﬁcient and safe. Moreover, the
developmental and implantation potential of biopsied 4-cell embryos
has not been thoroughly investigated so far. Since stable hESC lines
can be derived from single blastomeres at the 4- and 8-cell stage,
we need to determine which stage will combine optimal embryonic
development and an efﬁcient hESC derivation rate. The removal of
one or two cells at the 8-cell stage (12.5 and 25% of the total mass,
respectively) is generally used for PGD. A recent report showed
that the loss of two cells at the 8-cell stage interferes signiﬁcantly
with blastocyst formation and live birth rate (De Vos et al., 2009).
Safety of the biopsy at the 4-cell stage has also been questioned
(Hardy and Handyside, 1993). Nevertheless, recent studies on cryo-
damaged 4-cell stage embryos showed that the loss of one blastomere
(25%) does not affect the embryo’s implantation capacity (Edgar et al.,
2007). Since blastomeres are taken at random for PGD, plasticity/toti-
potency of all blastomeres is a prerequisite for both embryo develop-
ment and hESC derivation. We recently showed that single
blastomeres of a 4-cell stage human embryo are individually able to
develop into blastocysts with ICM and TE and therefore show charac-
teristics of plasticity/totipotency (Van de Velde et al., 2008).
However, evidence that all cells at the 8-cell stage show the same
characteristics has not yet been provided. If the cells become allocated
to ICM or TE after the embryonic genome activation, which in the
human occurs between the 4- and the 8-cell stage (Braude et al.,
1988), the random removal of one blastomere may affect both
embryo development and hESC derivation more at the 8-cell stage
than at the 4-cell stage. More basic research is needed to understand
potency, plasticity and allocation during human preimplantation
development.
In conclusion, we have shown for the ﬁrst time that a karyotypically
normal hESC line can be derived from a blastomere of a 4-cell stage
Figure 5 Karyotyping of VUB26_QUATRO: aCGH results showing a deletion of chromosome 18q23 and a duplication of chromosome 7q33 and
G-banding showing the derivative chromosome 18.
hESC lines from single 4-cell stage blastomeres 2715human embryo. We derived two hESC lines from distinct split 4-cell
stage embryos, proving that at least one of the 4-cell stage blasto-
meres is pluripotent. Our results may have far-reaching repercussions
on ethical dilemmas surrounding the destruction of preimplantation
embryos for hESC derivation.
Supplementary data
Supplementary data are available at http://humrep.oxfordjournals.
org/.
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